Crimson BioPharm
Brookline, US · Founded 2018 · Delaware corporation
Founders & leadership
JZ
Jean ZhaoNamed on SEC filing
HP
Haiying PengNamed on SEC filing
TR
Thomas RobertsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2019
▶$1MraisedOct 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedOct 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean ZhaoDirector
- Haiying PengExecutive Officer, Director
- Thomas RobertsDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Crimson BioPharm raised?
- Crimson BioPharm has disclosed $1M raised across 1 round.
- Where is Crimson BioPharm headquartered?
- Crimson BioPharm is headquartered in Brookline, US.